MedPath

Effects of consumption of the fatty acid on nasal and eye allergic reactions in healthy Japanese

Not Applicable
Conditions
Healthy Japanese
Registration Number
JPRN-UMIN000052624
Lead Sponsor
ORTHOMEDICO Inc.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
68
Inclusion Criteria

Not provided

Exclusion Criteria

Individuals who 1. are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. are currently undergoing treatment for cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. take "Foods for Specified Health Uses," "Foods with Functional Claims," or other functional food/beverage at least four times a week 5. take functional food/beverage which may affect allergic reactions, such as beta-carotene, methylated catechins, lactic acid bacteria, bifidobacteria, rosmarinic acid, acetic acid bacteria, soy fermented polysaccharides, caffeic acid, luteolin, quercetin, hesperidin, or nobiletin at least four times a week 6. usually drink to excess (average of more than about 20 g/day as pure alcohol intake) {500 mL: a medium bottle of beer or about 1.5 cans of canned chu-hi, 180 mL: 1 go of sake or about 1.5 glasses of wine, 90 mL: half-go with shochu, 60 mL: a glass of whiskey brandy (double)} 7. are taking medications (including herbal medicines) and supplements 8. require to consecutively use medications which may affect nasal and eye allergic symptoms (antiallergic drugs, antihistamines, steroids, vasoconstrictors, antihypertensives, etc.) during this study 9. are allergic to medications and/or the test-food-related products (particularly gelatin) 10. have a nasal irrigation habit 11. do not go out more than once a week 12. cannot visit to the clinic at 12w and 15w 13. are pregnant, lactating, or planning to become pregnant during this study 14. have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate another study during this study 15. are judged as ineligible to participate in this study by the physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath